ARBs and mortality in myocardial infarction.
Opie
L H
LH
D047228:Angiotensin II Type 1 Receptor Blockers / Q000009:adverse effects / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003928:Diabetic Nephropathies / Q000401:mortality / Q000517:prevention & control; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy; D015201:Meta-Analysis as Topic; D009203:Myocardial Infarction / Q000209:etiology / Q000401:mortality* / Q000517:prevention & control*; D011379:Prognosis; D012306:Risk
D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors